Clinical Trial Update: Percutaneous Endoluminal Benign Biliary Laser [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a percutaneous endoluminal benign biliary laser for benign biliary strictures has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Biliary Stricture

Drugs mentioned

• Percutaneous Endoluminal Benign Biliary Laser

Snippet

Sponsor: University of California, Los Angeles | Conditions: Benign Biliary Strictures With Current or Prior Biliary Obstruction | Phase 4 | Status: TERMINATED